我科自93年3月至今,使用利分能联合化疗治疗恶性肿瘤60例,现报告如下。 1 临床资料 60例恶性肿瘤患者中肺癌17例,肝癌10例,乳腺癌4例,胃癌6例,食管癌3例,大肠癌7例,肾癌3例,骨肉瘤2例,淋巴瘤5例、鼻咽癌、卵巢癌、原发灶石明的腹腔转移癌各1例。以上患者除肝癌外其诊断均有病理或细胞学依据。本组患者男46例,女14例。年龄30～76岁,中位年龄58岁。有恶性胸 In our department since March 1993, 60 patients with malignant tumors have been treated with Licensin in combination with chemotherapy. The report is as follows. 1 Clinical data Among 60 patients with malignant tumors, 17 were lung cancer, 10 were liver cancer, 4 breast cancer, 6 gastric cancer, 3 esophageal cancer, 7 colorectal cancer, 3 kidney cancer, 2 osteosarcoma, and 5 lymphoma. Nasopharyngeal carcinoma, ovarian cancer, and primary tumor metastatic carcinoma of the abdomen were found in 1 patient each. In addition to liver cancer in patients with the above diagnosis have pathological or cytological basis. This group of patients were 46 males and 14 females. Age 30 to 76 years, median age 58 years. Vicious chest